Virologiemarkt – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPRE00006886
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 227
Buy Now

Der Virologiemarkt wird bis 2028 voraussichtlich 5.276,48 Millionen US-Dollar erreichen, gegenüber 4.108,27 Millionen US-Dollar im Jahr 2021; Von 2021 bis 2028 wird eine durchschnittliche jährliche Wachstumsrate von 3,6 % erwartet.Virologie gehört zu den wichtigsten Bereichen des Gesundheitssystems. Es findet umfangreiche Anwendung in der Impfstoffentwicklung, Diagnostik, Behandlungstherapie und anderen Bereichen. Die Marktteilnehmer der Virologie sind ständig an Produktinnovationen und -entwicklungen beteiligt, um den Wettbewerb auf dem Markt aufrechtzuerhalten. Sie erkunden verschiedene Spielräume für Produktinnovationen. Beispielsweise investieren Marktteilnehmer im Hinblick auf COVID-19 erheblich in die Entwicklung von Impfstoffen, Testkits und anderen damit verbundenen Produkten und Dienstleistungen. Nachfolgend finden Sie einige Marktentwicklungen im Zusammenhang mit dem Virologiemarkt.
  • Im August 2021 hat die US-amerikanische Food and Drug Administration (FDA) den ersten COVID-19-Impfstoff namens Pfizer-BioNTech zugelassen Covid-19 Impfung. Es wird als ComiRNAty (Koe-mir’-na-tee) vermarktet. Der Impfstoff soll eine COVID-19-Erkrankung bei Personen ab 16 Jahren verhindern. Es ist auch im Rahmen einer Notfallgenehmigung (EUA) erhältlich.

  • Im April 2021 brachte CerTest Biotec seinen CE-gekennzeichneten COVID-19-Diagnosetest für das BD MAX-System auf den Markt.

  • Im Mai 2020 erhielt Bio-Rad die FDA-Genehmigung für die Notfallzulassung für den COVID-19-Gesamtantikörpertest.

  • Im Mai 2020 brachte Aalto Bio Reagents neue rekombinante eukaryotische SARS-CoV-2 S1-S2 Spike-Proteine auf den Markt.


Somit fördert eine solche aktive Beteiligung der Marktteilnehmer durch Produktinnovationen und staatliche Unterstützung in verschiedenen Ländern das Wachstum des Virologiemarktes.Lukrative Regionen für den Virologie-Markt MarkteinblickeDie zunehmende Akzeptanz minimalinvasiver und nicht-invasiver ästhetischer Verfahren treibt das Wachstum des Virologie-Marktes voranViren wie das Humane Immundefizienzvirus (HIV), das Grippevirus, das Zika-Virus, das Ebola-Virus, SARS-CoV-2 und das Poliovirus infizieren große Bevölkerungsgruppen auf der ganzen Welt. Da das Virus ständig mutiert und weiterentwickelt, wird die Arzneimittelresistenz zu einer großen Herausforderung bei der Behandlung viraler Infektionen bei Menschen und Tieren. Ein Virus wird je nach Typ über verschiedene Medien übertragen. Einige Viren verursachen beispielsweise respiratorische Viruserkrankungen wie Grippe, Erkältung und Respiratory-Syncytial-Virus-Infektionen und werden über Tröpfchen übertragen, die beim Husten oder Niesen entstehen, während einige gastrointestinale Viruserkrankungen durch direkten Kontakt mit dem Kot von Infizierten übertragen werden Menschen oder durch kontaminierte Lebensmittel oder Wasser. Laut der UNAIDS Global HIV & AIDS-Statistik waren im Jahr 2020 weltweit mehr als 37,7 Millionen Menschen mit HIV infiziert.Das Internationale Komitee zur Taxonomie von Viren (ICTV) erklärte das neuartige Coronavirus, das COVID- 19 als Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) im Februar 2020. Das Virus hat seit seinem Ausbruch mehrere Mutationen erfahren, was die Schwere der COVID-19-Pandemie noch verstärkt hat. Laut den COVID-19-Trackerdaten der Centers for Disease Control and Prevention (CDC) beträgt die Sieben-Tage-Fallrate pro 100.000 im August 2021 beispielsweise 299,4, und in den USA wurden über 164.952 neue Fälle gemeldet. Darüber hinaus belief sich die Gesamtzahl der COVID-19-Fälle nach Angaben des Europäischen Zentrums für die Prävention und die Kontrolle von Krankheiten im August 2021 auf etwa 36.307.572 Patienten im Europäischen Wirtschaftsraum (EWR). Daher treibt die steigende Prävalenz von Virusinfektionen das Wachstum des Virologiemarktes voran.Typbasierte ErkenntnisseDer Virologiemarkt basiert auf dem Typ weiter unterteilt in diagnostische Tests, Techniken zur Kontrolle viraler Infektionen, antivirale Therapeutika und Interferone. Im Jahr 2021 wird das Segment der diagnostischen Tests voraussichtlich den größten Marktanteil halten, und das Segment der Techniken zur Kontrolle viraler Infektionen wird im Zeitraum 2021–2028 voraussichtlich die höchste CAGR verzeichnen. Virologiemarkt, nach Produkt (2021 und 2028) Anwendungsbasierte ErkenntnisseBasierend auf der Anwendung ist der Markt in Haut- und Weichteilinfektionen unterteilt. Infektionen der Atemwege, Infektionen des Magen-Darm-Trakts, sexuell übertragbare Krankheiten, Harnwegsinfektionen und andere. Schätzungen zufolge wird das Segment Atemwegsinfektionen im Jahr 2021 den größten Marktanteil halten und zwischen 2021 und 2028 voraussichtlich die höchste CAGR verzeichnen.Strategische EinblickeUnternehmen, die auf dem Virologiemarkt tätig sind, legen Wert auf Übernahme der Produktinnovationsstrategie, um den sich entwickelnden Kundenanforderungen auf der ganzen Welt gerecht zu werden, was es ihnen auch ermöglicht, ihren Markennamen auf dem globalen Markt zu behaupten.Virologiemarkt – SegmentierungNach Typ
  • Diagnosetest
    • DNA-Virustest

    • RNA-Virustest
    • Andere



  • Techniken zur Virusinfektionskontrolle
    • Aktive Prophylaxe

    • Passive Prophylaxe


    < /li>
  • Antivirale Therapeutika
    • Viruzide Wirkstoffe

    • Antivirale Wirkstoffe

    • Immunmodulatoren



  • Interferone< span class="MsoCommentReference">


Nach Anwendung
  • Haut- und Weichteilinfektionen

  • Infektionen der Atemwege

  • < li>Magen-Darm-Trakt-Infektionen
  • Sexuell übertragbare Krankheiten

  • Harnwegs-Infektionen

  • Andere


Nach Endbenutzer
  • Krankenhäuser

  • Diagnoselabore

  • Pharmazeutische und biotechnologische Unternehmen

  • Forschungs- und akademische Institute


Nach Geografie
  • Nordamerika
    • USA

    • Kanada

    • Mexiko


    • Europa
      • Frankreich

      • Deutschland

      • Italien

      • Großbritannien

      • Spanien< /li>
      • Restliches Europa



    • Asien-Pazifik
      • China

      • Indien

      • Südkorea

      • Japan

      • Australien

      • Rest von APAC



    • Naher Osten und Afrika
      • Südafrika

      • Saudi-Arabien

      • VAE

      • Rest von MEA



    • Süd- und Mittelamerika < ul>
    • Brasilien

    • Argentinien

    • Rest von SCAM




Unternehmensprofile
  • Abbott

  • Johnson & Johnson Services, Inc.

  • < li>F. Hoffmann-LA Roche Ltd.
  • Thermo Fisher Scientific, Inc.

  • Qiagen

  • < li>Illumina, Inc.
  • Siemens AG

  • GlaxoSmithKline Plc

  • < li>Gilead Sciences, Inc.
  • AbbVie, Inc.auf den jeweiligen Websites angegebene Urheberrechtsnamen.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is Virology?

Virology is a detailed study of viruses that focuses on the structure, classification, evolution, and genetics of viruses. The virology market caters to the prevention and development of treatments for several viral diseases. The increasing prevalence of emerging infectious diseases (EIDs)—chikungunya, Ebola, West Nile virus, severe acute respiratory syndrome (SARS), and Lyme disease is driving the growth of the virology market. The key driving factors for the market growth are, rising prevalence of viral infections and other infectious diseases along with growing awareness about diagnosis and treatment of the disease.

What are the factors impacting for the virology market?

The factors that are driving and restraining factors that will affect virology market in the coming years. Factors such as rising prevalence of viral infectious diseases and increasing product launches, are driving the market growth. However, availability of alternative products and high cost of production of products are likely to hamper the growth of the market.

Who are the major players in the virology market?

The virology market majorly consists of the players such as Abbott, Johnson & Johnson Services, Inc., F. Hoffmann-LA Roche Ltd., Thermo Fisher Scientific, Inc., Qiagen, Illumina, Inc., Siemens AG, GlaxoSmithKline Plc, Gilead Sciences, Inc., and AbbVie, Inc. are amongst others.

What is the market value of virology market based on region?

The global virology market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America dominates the global virology market due to factors such as technological advancement, increasing product launches, and increasing investment in healthcare and research. The transmission of infectious diseases globally has made diagnosis mandatory for travelers. Today, the diseases are spreading faster around the world, which is further bolstering the demand for diagnostic tools as they can help control the outbreak at an early stage. For instance, in September 2019, the FDA approved OraQuick Ebola Rapid Antigen Test, a new rapid diagnostic test for Ebola in the US.

Asia Pacific is expected to be the fastest growing region Asia Pacific is expected to expand at a high growth rate due to large patient population, increasing government support to provide better healthcare services, and increasing product launches by market players. For instance, in 2018, Cepheid initiated the HBDC Access Program1 for the diagnosis of HIV, viral hepatitis (HCV), and human papillomavirus (HPV)2 at a relatively lower price. The company is aiming to make tests that would be more accessible to lower-income countries.

Which is the most influencing segment growing in the virology market report?

The global virology market based on based on type is segmented into diagnostic test, viral infection controlling techniques, antiviral therapeutics, and interferons. In 2021, Antiviral Therapeutics segment is estimated to account for the largest market share in the global virology market. the growth can be attributed to increasing prevalence of human immunodeficiency virus (HIV) and increasing research and development investment by private and public companies for antiviral drugs.

The List of Companies - Virology Market

  1. Abbott
  2. Johnson And Johnson Services, Inc.
  3. F. HOFFMANN-LA ROCHE LTD.
  4. THERMO FISHER SCIENTIFIC INC.
  5. QIAGEN
  6. Illumina, Inc.
  7. Siemens AG
  8. Glaxosmithkline Plc
  9. Abbvie Inc.
  10. Gilead Sciences, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports